Latest papers

Msh6 Protects Mature B Cells from Lymphoma by Preserving Genomic Stability

MSH6 and MUTYH deficiency is a frequent event in early-onset colorectal cancer.

Prognostic impact of microsatellite instability in colorectal cancer patients treated with adjuvant FOLFOX.

NRAS mutations are rare in colorectal cancer.

Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.

Cigarette smoking and colorectal cancer risk by molecularly defined subtypes.

Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.

Discrimination of patients with microsatellite instability colon cancer using 1H HR MAS MR spectroscopy and chemometric analysis.

BRAF mutations, microsatellite instability status and cyclin D1 expression predict metastatic colorectal patients' outcome.

Mitochondrial microsatellite instability in gastric cancer and gastric epithelial dysplasia as a precancerous lesion.

Somatic DNA alterations in lung epithelial barrier cells in COPD patients

Role of the Serrated Pathway in Colorectal Cancer Pathogenesis

[Difference of colon cancer and rectal cancer-from the view of an oncological physician].

MMP-7 and SGCE as distinctive molecular factors in sporadic colorectal cancers from the mutator phenotype pathway.

Taiwan hospital-based detection of Lynch syndrome distinguishes 2 types of microsatellite instabilities in colorectal cancers.

Role of BMP3 in progression of gastric carcinoma in Chinese people.

Lynch syndrome among gynecologic oncology patients meeting Bethesda guidelines for screening.

Microsatellite instability in colorectal cancer-the stable evidence.

Noncolonic cancer stem cells in bone marrow of colorectal cancer patients.

K-Ras and MSI: potential markers of both patient prognosis and treatment efficacy.